Aidapak Recalls Trazodone Tablets Due to Potential Labeling Errors
Aidapak Services, LLC is recalling Trazodone HCl 50 mg tablets because they may be mislabeled as Dexamethasone, Docusate Sodium, or Guanfacine.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (mislabeling) without reported injuries or illnesses, fitting the criteria for a moderate severity score.
Plain-English summary
Aidapak Services, LLC is recalling Trazodone HCl 50 mg tablets (NDC 50111043301) due to a labeling mixup. The recalled product may be potentially mislabeled as Dexamethasone 1 mg tablets, Docusate Sodium 250 mg capsules, or Guanfacine HCl 1 mg tablets.
The affected Trazodone tablets were repacked and distributed in Arizona, California, Oregon, and Washington. Specific pedigree codes and expiration dates are associated with the recall, including Pedigree AD37088_4 (EXP 5/9/2014), AD54562_1 (EXP 5/20/2014), and AD39611_4 (EXP 5/14/2014).
Consumers should check their medication packaging for the NDC 50111043301 and the specific pedigree codes listed in the recall notice. If the medication matches the recalled description, patients should contact their healthcare provider or pharmacist for guidance on obtaining a replacement or alternative treatment.
The recalled product
- Product
- traZODone HCl Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50111043301
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- traZODone HCl
- Tablet
- 50 mg has the following codes Pedigree: AD37088_4
- EXP: 5/9/2014
- Pedigree: AD54562_1
- EXP: 5/20/2014
- Pedigree: AD39611_4
- EXP: 5/14/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- SevereThioridazine HCL Tablets Recalled for Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Guanfacine HC Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- HighAidapak Recalls Guanfacine Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Hydrocortisone Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateFDA Recalls Nefazodone Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Chlorothalidone Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29